<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S2948 IS: Medicaid Generic Drug Price Fairness Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2014-11-20</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress><session>2d Session</session>
		<legis-num>S. 2948</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20141120">November 20, 2014</action-date>
			<action-desc><sponsor name-id="S313">Mr. Sanders</sponsor> introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSFI00">Committee on Finance</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To extend the requirement that drug manufacturers that increase prices faster than inflation pay an
			 additional rebate to State Medicaid programs to include manufacturers of
			 generic drugs.</official-title>
	</form>
	<legis-body style="OLC">
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short title</header>
			<text display-inline="no-display-inline">This Act may be cited as the
		  <quote><short-title>Medicaid Generic Drug Price Fairness Act</short-title></quote>.</text>
		</section><section id="id2E09A6D517AD4ED997B45AA263D0544C"><enum>2.</enum><header>Applying the Medicaid additional rebate requirement to manufacturers of generic drugs</header><subsection id="id5BCCBA047F7F49AA88FC833B33D0C8B7"><enum>(a)</enum><header>In general</header><text>Section 1927(c)(3)(A) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1396r-8">42 U.S.C. 1396r–8(c)(3)(A)</external-xref>) is amended—</text><paragraph id="id3A84F86C6E3D4129834A369F0BEFB3D3"><enum>(1)</enum><text>in clause (ii), by striking the period and inserting <quote>,</quote>; and</text></paragraph><paragraph id="idF66A9062215A42B3BB9AF090254BEE7C"><enum>(2)</enum><text>by adding at the end the following flush text:</text><quoted-block display-inline="no-display-inline" id="id5C896D92C7744A219923E334906F0B02" style="OLC"><quoted-block-continuation-text quoted-block-continuation-text-level="subparagraph">and shall be increased by an amount determined in the same manner as the increase in the amount of
			 a rebate for a single source drug or an innovator
			 multiple source drug is determined under paragraph (2).</quoted-block-continuation-text><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="id3D8045E94C7843B5A7FCFC7D7E3F5D52"><enum>(b)</enum><header>Effective date</header><text>The amendments made by this section shall apply to rebate periods beginning on or after the date of
			 enactment of this Act.</text>
			</subsection></section></legis-body>
</bill>


